European Medicines Agency, Amsterdam, the Netherlands
The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.
Documents
Minutes of the CHMP meeting 29 March - 1 April 2016
AdoptedReference Number: EMA/312797/2016Summary:
In accordance with the Agency’s health and safety policy, delegates are to be briefed on health, safety and emergency information and procedures prior to the start of the meeting.